#75 – Breakpoints Talks Breakpoints: Aminoglycosides
Breakpoints
00:00
Toba and Pseutomonas: A Comparison
Toba and pseudomonas didn't look amazing, okay? And it still has the same caveat as for the enterobacteralis. It wasn't completely dead, like with gente and a little bit and somewhat so with ammication. So we didn't want to completely destroy ammication and it looked slightly better than gente, but it was still pretty bad. We left it for UTI for countries that might not have other novel beta lactamase inhibitors,. basically.
Transcript
Play full episode
